Advertisement
CUTR 외환 뉴스
CUTERA Says FDA Clears AviClear As Long-Term Treatment For Mild To Severe Acne
Dermatology solutions provider CUTERA, INC. (CUTR) announced Thursday a new U.S. Food and Drug Administration clearance of AviClear as a long-term treatment for mild to severe inflammatory acne vulgaris. This is the first acne therapy to claim long term effectiveness for mild, moderate and severe acne.
RTTNews
|
806 일 전
